How I'd invest $10,000 into ASX shares today

This is how I'd invest $10,000 into ASX shares today.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The ASX is throwing up a lot of different investment opportunities at the moment. The ASX Index as a whole is fairly close to its multi-year high, but there are a number of ASX shares that look attractive to me.

Only by investing differently to most people can you beat the average. Of course, getting the average result for most people would be perfectly acceptable. An investment in BetaShares Australia 200 ETF (ASX: A200) would do quite well for Aussie investors.

But I think there are a number of investments that could beat the ASX's returns over the next few years:

WAM Global Limited (ASX: WGB) – $3,500

WAM Global is the listed investment company (LIC) in the Wilson Asset Management stable that invests internationally. If it is as successful as WAM Capital Limited (ASX: WAM) over the long-term then WAM Global will do very well.

Until the February 2019 NTA report is announced we won't officially know the discount to the net tangible assets per share it's trading at, but it seems as though it's trading at a discount of around 10%.

WAM Chairman and CIO Geoff Wilson has been busily buying WAM Global shares over last week, which says to me it's trading at good value today.

Vanguard FTSE Asia Ex Japan Shares Index ETF (ASX: VAE) – $3,000

Charlie Munger himself has said that China may offer the best investment opportunities because businesses are valued at a cheaper price there compared to their western counterparts.

This Vanguard Asian ETF has around 850 holdings, which mostly eliminates individual share risk. Although some people would argue that Chinese businesses have a high level of government and governance risks.

However, with the index as a whole having a price/earnings ratio of only 12x it seems cheap, particularly considering its earnings growth rate is 11.5% and the return on equity (ROE) ratio is 15.8% according to Vanguard.

Naos Emerging Opportunities Company Ltd (ASX: NCC) – $2,000

I really respect an investment manager who is willing to make high-conviction investments in shares that could beat the market. If you're going to be different from the index, why not really go for it? What good is having your 40th best idea in the portfolio?

Small caps also have the potential to beat the general market return over time, particularly because they are covered less by analysts and so therefore there is a higher chance of valuation mispricing.

All of the above is how Naos invests through this listed investment company (LIC).

Since inception it has beaten the ASX small cap index by 7% per annum before fees. With an NTA of $1.13 at the end of February, the Naos LIC was trading at a discount of 5.3%, which partly compensates us for the volatility/risk that illiquidity can create with microcap shares in downturns.

It currently offers a trailing grossed-up dividend yield of 9.8%.

Costa Group Holdings Ltd (ASX: CGC) – $1,500

It's getting harder to outperform with mid-cap and large-cap shares at the moment, particularly with the economy faltering.

However, Costa could be one of the ones to outperform the market with the company predicting underlying profit growth of 'at least 30%' in 2019 and food prices returning to normal.

At around 21x FY19's estimated earnings, I think Costa looks pretty attractive right now.

Foolish takeaway

I think all four of the above ideas are capable of beating the ASX Index's return over the next few years. At the current prices it's hard to pick a favourite idea due to the discounts or low valuations they are each trading at.

Motley Fool contributor Tristan Harrison owns shares of COSTA GRP FPO, VANGUARD FTSE ASIA EX JAPAN SHARES INDEX ETF, and WAMGLOBAL FPO. The Motley Fool Australia owns shares of and has recommended COSTA GRP FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

A fit woman in workout gear flexes her muscles with two bigger people flexing behind her, indicating growth.
Growth Shares

3 monster stocks to hold for the next 3 years

These 3 ASX shares operate in different industries and could be worth holding for long-term growth over the next 3…

Read more »

Person pointing at an increasing blue graph which represents a rising share price.
Growth Shares

2 ASX growth shares to snap up while they're still down

Brokers see plenty of upside for these mainstay sector picks.

Read more »

Man pointing an upward line on a bar graph symbolising a rising share price.
Growth Shares

Why these ASX growth stocks could be much bigger in 2030 than today

These stocks have long growth runways and strong business models.

Read more »

A woman sits at her computer with her hand to her mouth and a contemplative smile on her face as she reads about the performance of Allkem shares on her computer
Growth Shares

3 incredible ASX growth shares to buy and hold forever in 2026

True long-term investing means owning businesses you’d be happy to hold through volatility, uncertainty, and decades of change.

Read more »

Happy work colleagues give each other a fist pump.
Growth Shares

2 shares to buy hand over fist before the ASX 200 soars higher in 2026

These shares are highly rated by brokers for a reason. Here's what you need to know about them.

Read more »

Buy now written on a red key with a shopping trolley on an Apple keyboard.
Broker Notes

Experts rate these 2 ASX shares as buys this month!

Leading analysts say these stocks are a buy.

Read more »

Happy healthcare workers in a labs
Technology Shares

Prediction: CSL shares could soar past $270 in 2026

Here's what to expect from the Australian-based global biotechnology company this year.

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Growth Shares

2 unstoppable ASX 200 stocks to buy in 2026 and hold forever

These blue chips could have very bright futures. Do you own them?

Read more »